TDOC Company Profile and Key Details

Q: Who are the executives of TDOC?

Ms. Courtney Kraemer McLeodDirector of CommunicationMr. Claus Torp Jensen Ph.D.Chief Innovation OfficerMr. Jason Nathanial GorevicChief Executive Officer & DirectorMr. Adam Christian VandervoortChief Legal Officer & Sec.Dr. George Byron BrooksCo-FounderMr. Andrew TuritzExecutive Vice President of Corporation Devel.Ms. Mala MurthyChief Financial OfficerMr. Richard J. NapolitanoSenior Vice President, Chief Accounting Officer & ControllerMr. Laizer D. KornwasserPres of Enterprise Growth & Global MarketsDr. Claus Torp Jensen Ph.D.Chief Innovation OfficerMr. Mike WatersChief Operating OfficerMr. Patrick Thomas Feeley C.F.A., CPAVice President of Investor RelationsMs. Stephany VerstraeteChief Marketing Officer & Engagement OfficerMr. Michael WatersChief Operating Officer

NYSE : TDOC

Teladoc Health

$6.16

0.075+1.23%

At Close 4:00 PM

62.23

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Teladoc Health, Inc. (TDOC) stock surged +1.23%, trading at $6.16 on NYSE, up from the previous close of $6.09. The stock opened at $6.12, fluctuating between $6.04 and $6.20 in the recent session.

Stock Snapshot

6.085

Prev. Close

1.12B

Market Cap

6.04

Day Low

-6.22

P/E Ratio

-0.99

EPS (TTM)

1.17

Cash Flow per Share

6.12

Open

181.68M

Number of Shares

6.195

Day High

98.9%

Free Float in %

14.01

Book Value

2.57M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 11, 2026	6.09	6.20	6.04	6.16	2.57M
Sep 10, 2026	6.08	6.21	6.05	6.09	2.52M
Sep 09, 2026	6.28	6.29	6.00	6.10	3.78M
Sep 08, 2026	6.17	6.38	6.15	6.26	3.76M
Sep 04, 2026	6.34	6.42	6.25	6.28	2.95M
Sep 03, 2026	6.51	6.61	6.39	6.47	2.57M
Sep 02, 2026	6.22	6.59	6.22	6.46	3.9M
Sep 01, 2026	6.25	6.39	6.23	6.26	3.45M
Aug 31, 2026	6.37	6.45	6.17	6.34	5.13M
Aug 28, 2026	6.40	6.59	6.40	6.50	3.67M
Aug 27, 2026	6.39	6.46	6.32	6.36	2.48M
Aug 26, 2026	6.14	6.38	6.13	6.33	3.07M
Aug 25, 2026	6.23	6.27	6.12	6.19	3.26M
Aug 24, 2026	6.37	6.40	6.17	6.20	3.17M
Aug 21, 2026	6.50	6.54	6.35	6.39	3.47M
Aug 20, 2026	6.63	6.82	6.47	6.49	3.02M
Aug 19, 2026	6.56	6.67	6.51	6.66	3.22M
Aug 18, 2026	6.54	6.67	6.41	6.47	4.23M
Aug 17, 2026	6.78	6.78	6.51	6.54	4.1M
Aug 14, 2026	6.87	6.96	6.79	6.81	3.07M

Contact Details

New York, NY 10017

United States

https://www.teladochealth.com 203 635 2002

About Company

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Stock Peers

HNGE

0.33+0.37%

Hinge Health, Inc.$88.59 CTEV

-0.76-2.07%

Claritev Corporation$35.98 DOCS

0.87+3.52%

Doximity, Inc.$25.58 MPLN

-0.36-1.53%

MultiPlan Corporation$23.15 AMWL

0.21+1.64%

American Well Corporation$13.00 PHR

0.14+1.38%

Phreesia, Inc.$10.31 AGTI

-0.05-0.50%

Agiliti, Inc.$10.05 EVH

0.02+0.48%

Evolent Health, Inc.$4.19 UPH

0.0251+9.13%

UpHealth, Inc.$0.30 UPH-WT

-0.0008-8.89%

$0.01

Company Overview

Teladoc Health, Inc. (NYSE:TDOC) closed at $6.16 USD, gaining $0.08 (1.23%) from the previous close of $6.08. The stock is currently mid-range between its 52-week high and low $4.40 and $9.89. With a market capitalization of about $1.12 billion, Teladoc Health, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~2.12). Key stats such as the average daily volume over the past year has been around 4.65 million shares, volume is running light vs its 52-week average. Headquartered in New York, NY, Teladoc Health, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Charles Divita, the company employs approximately 5,124 people and listed since June 30, 2015. Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally.

Technical Performance

TDOC has shown weak momentum, losing -16.28% over the past week and -28.84% over the past quarter, though year-to-date performance is down -13.29%. Short-term trend indicators are bullishly aligned (SMA20 9.35%, SMA50 -12.43%, SMA200 -27.13%). The stock’s 14-day RSI is 51.75 (neutral), while the ATR of 0.32 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -53.68% below its high and over 21.59% above its low. Average 10-day trading volume of 3.15 million shares is below the 3-month average of 4.59 million, indicating normal recent market interest.

Valuation Metrics

Teladoc Health, Inc. trades at a P/E ratio of -6.23, slightly below the S&P 500 average, with a price-to-sales ratio of 0.45 and a price-to-book ratio of 0.85 suggesting the stock is closer to book value. The P/FCF stands at 4.99, also above market averages.

Dividend & Fair Value

Teladoc Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $21.08. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Teladoc Health, Inc. generated EPS of -$1.28 over the past year. Five-year average earnings growth is -33.66%. Wall Street analysts project EPS growth of 35.74% annually over the next five years. The latest quarter delivered EPS of -$0.21. The next quarter is forecast at -$0.26. Next year's EPS is expected at $13.28. Analyst sentiment is neutral. Analyst rating data shows there are 2 Strong Buy ratings, 5 Buy ratings, 20 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $12.00 to $6.00. The high target offers 94.81% upside. The low target suggests -2.6% downside. The mean target is $8.93. This offers 44.97% upside. Teladoc Health, Inc. earnings surprise history is a mixed track record. The quarter that ended July 29, 2026, missed forecasts by -12.5%. The prior quarter beat by 5.52%. Over the last six quarters, Apple has recorded several small beats. These include -42.42% in April 30, 2025.

Shareholding & Insider Activity

Teladoc Health, Inc. has 180.51 million shares outstanding. The public float is 179.34 million shares, elevated short interest at 15.62% of float. This equals 28.06 million shares. The short ratio is 6.25 days. Institutional investors hold 87.57% of the float. Insiders own 0.72%. GOREVIC JASON N holds 653.07 thousand shares, DIVITA CHARLES III has 440.54 thousand shares and Murthy Mala has 142.38 thousand shares. Over the past six months, insider transactions show net selling. They sold 91.46 thousand shares across 14 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Teladoc Health generated $2.60B in revenue, or $15.81 per share. Gross margin was 70.80%, operating margin -9.55%, and net profit margin -8.47%. Returns are negative, with ROA at -5.02% and ROE at -9.47%.
On valuation metrics, Teladoc Health trades at a P/E of -6.23, P/S of 0.45 and P/B of 0.85. Liquidity is tight, with a current ratio of 0.83 and quick ratio of 0.81. Operationally, the company’s inventory turnover is 22.86 and cash conversion cycle is 29.05 days. Debt-to-equity is 0.79, supported by a cash flow-to-debt ratio of 0.25.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Teladoc Health posted revenue of $2.60B, down slightly from $2.41B in the prior quarter. Gross profit was $1.84B (margin 70.80%). Operating income was - $248.55M (margin -9.6%). Net income was- $220.37M (EPS - $1.34).
The company ended the quarter with $1.12B in cash and short-term investments, a total debt of $1.59B, and net debt of $468.60M. Total assets were $4.39B, with equity of $2.33B. Financials further reflected stability, with operating cash flow of $350.02M, free cash flow of $193.67M, and capital expenditures of - $156.35M.

Price Forecast & Outlook

Our AI price prediction model suggests that Teladoc Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -9.58%, with price expected at $5.57 by September 25, 2026, within a range of $4.84 to $6.32 3-Month Outlook: Projected fall of -58.12%, reaching $2.58 by December 10, 2026, with a range of $2.23 to $2.84. 1-Year Outlook: Projected gain of 113.64%, with price at $13.16 by September 10, 2027, within a range of $0.00 to $18.81.

Key Takeaways

Teladoc Health, Inc. (NYSE:TDOC) shares are down -13.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Teladoc Health, Inc. trading at a premium to the broader market with a P/E of -6.23. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $20.29, suggesting 229.38% upside. Our AI forecast model points to short-term weakness (-9.58% over two weeks), a medium-term fall (-58.12% over three months), and a longer-term gain (113.64% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Teladoc Health, Inc. (TDOC) stock price?

Teladoc Health, Inc. (NYSE: TDOC) stock price is $6.16 in the last trading session. During the trading session, TDOC stock reached the peak price of $6.20 while $6.04 was the lowest point it dropped to. The percentage change in TDOC stock occurred in the recent session was 1.23% while the dollar amount for the price change in TDOC stock was $0.08.

TDOC's industry and sector of operation?

The NYSE listed TDOC is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Teladoc Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TDOC?

Ms. Courtney Kraemer McLeod
Director of Communication
Mr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Jason Nathanial Gorevic
Chief Executive Officer & Director
Mr. Adam Christian Vandervoort
Chief Legal Officer & Sec.
Dr. George Byron Brooks
Co-Founder
Mr. Andrew Turitz
Executive Vice President of Corporation Devel.
Ms. Mala Murthy
Chief Financial Officer
Mr. Richard J. Napolitano
Senior Vice President, Chief Accounting Officer & Controller
Mr. Laizer D. Kornwasser
Pres of Enterprise Growth & Global Markets
Dr. Claus Torp Jensen Ph.D.
Chief Innovation Officer
Mr. Mike Waters
Chief Operating Officer
Mr. Patrick Thomas Feeley C.F.A., CPA
Vice President of Investor Relations
Ms. Stephany Verstraete
Chief Marketing Officer & Engagement Officer
Mr. Michael Waters
Chief Operating Officer

How TDOC did perform over past 52-week?

TDOC's closing price is 40% higher than its 52-week low of $4.40 where as its distance from 52-week high of $9.89 is -37.7%.

How many employees does TDOC have?

Number of TDOC employees currently stands at 5,124.

Link for TDOC official website?

Official Website of TDOC is: https://www.teladochealth.com

How do I contact TDOC?

TDOC could be contacted at phone 203 635 2002 and can also be accessed through its website. TDOC operates from 155 E 44th Street, New York, NY 10017, United States.

How many shares of TDOC are traded daily?

TDOC stock volume for the day was 2.57M shares. The average number of TDOC shares traded daily for last 3 months was 4.65M.

What is the market cap of TDOC currently?

The market value of TDOC currently stands at $1.12B with its latest stock price at $6.16 and 181.68M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	5124
Beta	2.12
Sales or Revenue	$2.60B
5Y Sales Change%	1.528%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Information Services

TDOC Company Profile and Key Details

Teladoc Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Valuation Metrics

Price Forecast & Outlook

Key Takeaways